Feb. 20, 2004 — Galantamine may slow clinical progression of Alzheimer disease (AD) during 36 months of continuous use, according to the results of an open-label extension study published in the ...
Please provide your email address to receive an email when new articles are posted on . Cholinesterase inhibitors provided moderate but persistent benefits in patients with Alzheimer’s dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results